Type 2 diabetes patients taking Mounjaro experienced an 8% lower risk of cardiovascular-related death, heart attack, or stroke compared to people taking Trulicity, Lilly said Thursday
Townsend DM, Manevich Y, He L et al (2008) Novel role for glutathione S-transferase
Get the clinical data, management tips, and real timelines from Phase 2 trial results
This blog explores how Rybelsus works for weight loss, its side effects, comparisons with other medications, and practical tips for optimal results
Country Comparison United States vs Mexico and Canada Approved in all three countries for type 2 diabetes and cardiovascular risk reduction
GLP-1 and GLP-1 receptor agonists also reduce intestinal motility and this may affect nutrient absorption